Skip to main content
Log in

Aspirin induces apoptosis in human leukemia cells independently of NF-κB and MAPKs through alteration of the Mcl-1/Noxa balance

  • Original Paper
  • Published:
Apoptosis Aims and scope Submit manuscript

Abstract

Aspirin and other non-steroidal anti-inflammatory drugs induce apoptosis in most cell types. In this study we examined the mechanism of aspirin-induced apoptosis in human leukemia cells. We analyzed the role of nuclear factor-κB (NF-κB) and mitogen-activated protein kinases (MAPKs) pathways. Furthermore, we studied the changes induced by aspirin in some genes involved in the control of apoptosis at mRNA level, by performing reverse transcriptase multiplex ligation-dependent probe amplification (RT-MLPA), and at protein level by Western blot. Our results show that aspirin induced apoptosis in leukemia Jurkat T cells independently of NF-κB. Although aspirin induced p38 MAPK and c-Jun N-terminal kinase activation, selective inhibitors of these kinases did not inhibit aspirin-induced apoptosis. We studied the regulation of Bcl-2 family members in aspirin-induced apoptosis. Aspirin increased the mRNA levels of some pro-apoptotic members, such as BIM, NOXA, BMF or PUMA, but their protein levels did not change. In contrast, aspirin decreased the protein levels of Mcl-1. Interestingly, in the presence of aspirin the protein levels of Noxa remained high. This alteration of the Mcl-1/Noxa balance was also found in other leukemia cell lines and primary chronic lymphocytic leukemia cells (CLL). Furthermore, in CLL cells aspirin induced an increase in the protein levels of Noxa. Knockdown of Noxa or Puma significantly attenuated aspirin-induced apoptosis. These results indicate that aspirin induces apoptosis through alteration of the Mcl-1/Noxa balance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Abbreviations

NSAIDs:

Non-steroidal anti-inflammatory drugs

NF-κB:

Nuclear factor-κB

MAPK:

Mitogen-activated protein kinase

COX:

Cyclooxygenase

IκB:

Inhibitors of κB

IKKβ:

IκB kinase β

ERK:

Extracellular-regulated kinase

JNK:

c-Jun N-terminal kinase

TPA:

12-O-tetradecanoylphorbol 13-acetate

MAPKAPK 2:

MAPK-activated protein kinase 2

PI:

Propidium iodide

PPARδ:

Peroxisome proliferator-activated receptor δ

EMSA:

Electrophoretic mobility shift assay

ASA:

Aspirin

CHX:

Cycloheximide

RT-MLPA:

Reverse transcriptase multiplex ligation-dependent probe amplification

CLL:

Chronic lymphocytic leukemia

siRNA:

Small interfering RNA

MEFs:

Mouse embryonic fibroblasts

PBLs:

Peripheral blood lymphocytes

References

  1. Jana NR (2008) NSAIDs and apoptosis. Cell Mol Life Sci 65:1295–1301

    Article  CAS  PubMed  Google Scholar 

  2. Bellosillo B, Pique M, Barragan M, Castano E, Villamor N, Colomer D, Montserrat E, Pons G, Gil J (1998) Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells. Blood 92:1406–1414

    CAS  PubMed  Google Scholar 

  3. Pique M, Barragan M, Dalmau M, Bellosillo B, Pons G, Gil J (2000) Aspirin induces apoptosis through mitochondrial cytochrome c release. FEBS Lett 480:193–196

    Article  CAS  PubMed  Google Scholar 

  4. Iglesias-Serret D, Pique M, Gil J, Pons G, Lopez JM (2003) Transcriptional and translational control of Mcl-1 during apoptosis. Arch Biochem Biophys 417:141–152

    Article  CAS  PubMed  Google Scholar 

  5. de Groot DJ, de Vries EG, Groen HJ, de Jong S (2007) Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: from lab to clinic. Crit Rev Oncol Hematol 61:52–69

    Article  PubMed  Google Scholar 

  6. Cha YI, DuBois RN (2007) NSAIDs and cancer prevention: targets downstream of COX-2. Annu Rev Med 58:239–252

    Article  CAS  PubMed  Google Scholar 

  7. Zhang X, Morham SG, Langenbach R, Young DA (1999) Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts. J Exp Med 190:451–459

    Article  CAS  PubMed  Google Scholar 

  8. He TC, Chan TA, Vogelstein B, Kinzler KW (1999) PPAR delta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99:335–345

    Article  CAS  PubMed  Google Scholar 

  9. Park BH, Vogelstein B, Kinzler KW (2001) Genetic disruption of PPAR delta decreases the tumorigenicity of human colon cancer cells. Proc Natl Acad Sci USA 98:2598–2603

    Article  CAS  PubMed  Google Scholar 

  10. Lopez JM, Fernandez MA, Pique M, Gil J (2004) Aspirin-induced apoptosis in jurkat cells is not mediated by peroxisome proliferator-activated receptor delta. Mol Cell Biochem 266:57–63

    Article  CAS  PubMed  Google Scholar 

  11. Tegeder I, Pfeilschifter J, Geisslinger G (2001) Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J 15:2057–2072

    Article  CAS  PubMed  Google Scholar 

  12. Kopp E, Ghosh S (1994) Inhibition of NF-Kappa B by sodium salicylate and aspirin. Science 265:956–959

    Article  CAS  PubMed  Google Scholar 

  13. Karin M, Greten FR (2005) NF-KappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5:749–759

    Article  CAS  PubMed  Google Scholar 

  14. Yin MJ, Yamamoto Y, Gaynor RB (1998) The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(Kappa)B kinase-beta. Nature 396:77–80

    Article  CAS  PubMed  Google Scholar 

  15. Zhuang S, Schnellmann RG (2006) A death-promoting role for extracellular signal-regulated kinase. J Pharmacol Exp Ther 319:991–997

    Article  CAS  PubMed  Google Scholar 

  16. Zimmermann KC, Waterhouse NJ, Goldstein JC, Schuler M, Green DR (2000) Aspirin induces apoptosis through release of cytochrome c from mitochondria. Neoplasia 2:505–513

    Article  CAS  PubMed  Google Scholar 

  17. Youle RJ, Strasser A (2008) The BCL-2 Protein Family: Opposing Activities That Mediate Cell Death. Nat.Rev.Mol.Cell Biol. 9:47–59

    Article  CAS  PubMed  Google Scholar 

  18. Lindsten T, Ross AJ, King A, Zong WX, Rathmell JC, Shiels HA, Ulrich E, Waymire KG, Mahar P, Frauwirth K, Chen Y, Wei M, Eng VM, Adelman DM, Simon MC, Ma A, Golden JA, Evan G, Korsmeyer SJ, MacGregor GR, Thompson CB (2000) The combined functions of proapoptotic Bcl-2 family members Bak and Bax are essential for normal development of multiple tissues. Mol Cell 6:1389–1399

    Article  CAS  PubMed  Google Scholar 

  19. Iglesias-Serret D, de Frias M, Santidrian AF, Coll-Mulet L, Cosialls AM, Barragan M, Domingo A, Gil J, Pons G (2007) Regulation of the proapoptotic BH3-only protein BIM by glucocorticoids, survival signals and proteasome in chronic lymphocytic leukemia cells. Leukemia 21:281–287

    Article  CAS  PubMed  Google Scholar 

  20. Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR (1999) Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci USA 96:7563–7568

    Article  CAS  PubMed  Google Scholar 

  21. Meijerink JP, Mensink EJ, Wang K, Sedlak TW, Sloetjes AW, de Witte T, Waksman G, Korsmeyer SJ (1998) Hematopoietic malignancies demonstrate loss-of-function mutations of BAX. Blood 91:2991–2997

    CAS  PubMed  Google Scholar 

  22. Zhong Q, Gao W, Du F, Wang X (2005) Mule/ARF-BP1, a BH3-Only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 121:1085–1095

    Article  CAS  PubMed  Google Scholar 

  23. Schwenger P, Bellosta P, Vietor I, Basilico C, Skolnik EY, Vilcek J (1997) Sodium salicylate induces apoptosis via P38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced C-Jun N-terminal kinase/stress-activated protein kinase activation. Proc Natl Acad Sci USA 94:2869–2873

    Article  CAS  PubMed  Google Scholar 

  24. Derouet M, Thomas L, Moulding DA, Akgul C, Cross A, Moots RJ, Edwards SW (2006) Sodium salicylate promotes neutrophil apoptosis by stimulating caspase-dependent turnover of Mcl-1. J Immunol 176:957–965

    CAS  PubMed  Google Scholar 

  25. Zhang L, Yu J, Park BH, Kinzler KW, Vogelstein B (2000) Role of BAX in the apoptotic response to anticancer agents. Science 290:989–992

    Article  CAS  PubMed  Google Scholar 

  26. Ishihara T, Hoshino T, Namba T, Tanaka K, Mizushima T (2007) Involvement of up-regulation of PUMA in non-steroidal anti-inflammatory drug-induced apoptosis. Biochem Biophys Res Commun 356:711–717

    Article  CAS  PubMed  Google Scholar 

  27. Fritsch RM, Schneider G, Saur D, Scheibel M, Schmid RM (2007) Translational repression of MCL-1 couples stress-induced EIF2 alpha phosphorylation to mitochondrial apoptosis initiation. J Biol Chem 282:22551–22562

    Article  CAS  PubMed  Google Scholar 

  28. Cuconati A, Mukherjee C, Perez D, White E (2003) DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells. Genes Dev 17:2922–2932

    Article  CAS  PubMed  Google Scholar 

  29. Nijhawan D, Fang M, Traer E, Zhong Q, Gao W, Du F, Wang X (2003) Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev 17:1475–1486

    Article  CAS  PubMed  Google Scholar 

  30. Rahmani M, Davis EM, Bauer C, Dent P, Grant S (2005) Apoptosis induced by the kinase inhibitor BAY 43–9006 in human leukemia cells involves down-regulation of Mcl-1 through inhibition of translation. J Biol Chem 280:35217–35227

    Article  CAS  PubMed  Google Scholar 

  31. Dikshit P, Chatterjee M, Goswami A, Mishra A, Jana NR (2006) Aspirin induces apoptosis through the inhibition of proteasome function. J Biol Chem 281:29228–29235

    Article  CAS  PubMed  Google Scholar 

  32. Fennell DA, Chacko A, Mutti L (2008) BCL-2 family regulation by the 20S proteasome inhibitor bortezomib. Oncogene 27:1189–1197

    Article  CAS  PubMed  Google Scholar 

  33. Alves NL, Derks IA, Berk E, Spijker R, van Lier RA, Eldering E (2006) The noxa/Mcl-1 axis regulates susceptibility to apoptosis under glucose limitation in dividing T cells. Immunity 24:703–716

    Article  CAS  PubMed  Google Scholar 

  34. Mei Y, Xie C, Xie W, Tian X, Li M, Wu M (2007) Noxa/Mcl-1 balance regulates susceptibility of cells to camptothecin-induced apoptosis. Neoplasia. 9:871–881

    Article  CAS  PubMed  Google Scholar 

  35. Hallaert DY, Spijker R, Jak M, Derks IA, Alves NL, Wensveen FM, de Boer JP, de Jong D, Green SR, van Oers MH, Eldering E (2007) Crosstalk among Bcl-2 family members in B-CLL: seliciclib acts via the Mcl-1/Noxa axis and gradual exhaustion of Bcl-2 protection. Cell Death Differ 14:1958–1967

    Article  CAS  PubMed  Google Scholar 

  36. Nencioni A, Hua F, Dillon CP, Yokoo R, Scheiermann C, Cardone MH, Barbieri E, Rocco I, Garuti A, Wesselborg S, Belka C, Brossart P, Patrone F, Ballestrero A (2005) Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis. Blood 105:3255–3262

    Article  CAS  PubMed  Google Scholar 

  37. Hussain SR, Cheney CM, Johnson AJ, Lin TS, Grever MR, Caligiuri MA, Lucas DM, Byrd JC (2007) Mcl-1 is a relevant therapeutic target in acute and chronic lymphoid malignancies: down-regulation enhances rituximab-mediated apoptosis and complement-dependent cytotoxicity. Clin Cancer Res 13:2144–2150

    Article  CAS  PubMed  Google Scholar 

  38. Longo PG, Laurenti L, Gobessi S, Sica S, Leone G, Efremov DG (2008) The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells. Blood 111:846–855

    Article  CAS  PubMed  Google Scholar 

  39. Opferman JT, Letai A, Beard C, Sorcinelli MD, Ong CC, Korsmeyer SJ (2003) Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature 426:671–676

    Article  CAS  PubMed  Google Scholar 

  40. Smit LA, Hallaert DY, Spijker R, de Goeij B, Jaspers A, Kater AP, van Oers MH, van Noesel CJ, Eldering E (2007) Differential Noxa/Mcl-1 balance in peripheral versus lymph node chronic lymphocytic leukemia cells correlates with survival capacity. Blood 109:1660–1668

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We are grateful to Dr. Pura Muñoz and Dr. Francesc Ventura for kindly providing plasmids. We thank Alba Pérez-Perarnau and Camila Rubio for helpful discussions and suggestions. We also thank the Unitat de Biologia and the Unitat de Genòmica of the Serveis Cientificotècnics at the Universitat de Barcelona for their technical support. This study was supported by grants from the Ministerio de Educación y Ciencia and FEDER (SAF2007-60964) and from the Ministerio de Sanidad y Consumo (ISCIII-RETIC RD06/0020) to J.G. D.I.-S. is recipient of fellowship from the José Carreras International Leukemia Foundation (FIJC-07/ESP-FCAJAMADRID). M.d.F. is a recipient of a fellowship from the AGAUR-Generalitat de Catalunya, A.M.C. and D.M.G.-G. are recipients of research fellowships from the Ministerio de Educación y Ciencia. We thank the Language Services at the Universitat de Barcelona for correcting the English of the manuscript.

Conflict of interest

The authors declare no competing financial interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joan Gil.

Electronic supplementary material

Below is the link to the electronic supplementary material.

DOC 393 kb

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iglesias-Serret, D., Piqué, M., Barragán, M. et al. Aspirin induces apoptosis in human leukemia cells independently of NF-κB and MAPKs through alteration of the Mcl-1/Noxa balance. Apoptosis 15, 219–229 (2010). https://doi.org/10.1007/s10495-009-0424-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10495-009-0424-9

Keywords

Navigation